跳至主要内容
临床试验/NL-OMON53636
NL-OMON53636招募中2 期

Exercise during Neoadjuvant chemoradiation Treatment to improve rectal and esophageal cancer Outcome - pilot trial. - EXENTRO

Fysiologie0 个研究点目标入组 39 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
39

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Diagnosed with rectal or esophageal carcinoma
  • - Patients with rectal or esophageal carcinoma need to be scheduled for
  • treatment with neoadjuvant chemoradiation therapy
  • Oral capecitabine combined with concurrent radiotherapy (50 Gy in 25
  • fractions) for rectal cancer
  • CROSS regimen (carboplatin, paclitaxel with concurrent 41.4 Gy in 23
  • fractions radiation) for esophageal cancer
  • - Aged > 18 years

排除标准

  • A participant who meets any of the following criteria will be excluded from
  • participation in this study:
  • - Unable to perform basic activities of daily living such as walking or biking
  • - Presence of other disabling co-morbidity that might hamper or endanger
  • physical exercise e.g. heart failure, chronic obstructive pulmonary disease,
  • orthopaedic conditions and neurological disorders
  • - Presence of cognitive disorders or severe emotional instability (e.g.,
  • Schizophrenia, Alzheimer, alcohol addiction)
  • - Immunodeficiency (primary or secondary)
  • - Insufficient mastery of the Dutch language
  • - Participation in another exercise and/or dietary intervention study at the
  • same time. Participation in Fit4Surgery is allowed as this starts after NCRT
  • and we have alighted the logistics.
  • - Already participating in structured vigorous aerobic and/or resistance
  • exercise >= 2 times per week comparable to our intervention and planning to
  • continue this throughout the period of neoadjuvant chemoradiation.

研究者

发起方
Fysiologie

相似试验

Exercise during Neoadjuvant chemoradiation Treatment... | 临床试验